Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02885935
Other study ID # 138447
Secondary ID
Status Completed
Phase N/A
First received August 24, 2016
Last updated August 26, 2016
Start date April 2013
Est. completion date September 2014

Study information

Verified date August 2016
Source University of Arkansas
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The investigators examined the effects of 4-week dietary protein intake in mixed meals at two levels of protein amount on whole body glucose metabolisms in older adults with metabolic syndrome.


Description:

The investigators investigated changes in insulin sensitivity before and after 4 weeks of dietary intervention and control in subjects with metabolic syndrome. Two groups of subjects were studied before and after a weight maintenance diet. Group 1 was fed a common American diet with a macronutrient distribution of 10% protein, 55% carbohydrates, and 35% fat. Group 2 consumed a higher protein diet (20%; 1.4 g/kg/d of protein). Carbohydrate intake was lower in Group 2 (45%), with fat intake (largely derived from dairy sources) similar between groups. Glucose utilization and endogenous glucose production were determined during an oral glucose tolerance test (OGTT) with a novel double-tracer approach. The secondary aim was to determine the effect of a diet high in dairy consumption on blood lipid profiles. The investigators measured blood lipids before and after dietary intervention in each group.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 45 Years to 75 Years
Eligibility Inclusion Criteria:

- Men and women, ages 45-75 years AND

- BMI greater than 30 kg/m2 AND

- Two of the following conditions:

- Plasma triglycerides > 130 mg/dl

- HDL < 40 mg/dl in men or 50 mg/dl in women

- elevated screening blood pressure (systolic > 140 or diastolic >90 mm Hg) or taking medication for hypertension

- fasting plasma glucose > 100mg/dl

Exclusion Criteria:

- Hemoglobin A1c > 7.5

- History of malignancy in the 6 months prior to enrollment

- History of lactose intolerance or dairy allergy

- History of gastrointestinal bypass surgery (Lapband, etc)

- History of a chronic inflammatory condition or disease (Lupus, HIV/AIDS, etc)

- Subjects who do not or will not eat animal proteins

- Subjects who cannot refrain from consuming protein or amino acid supplements during their participation in this study

- Subjects who use insulin to control their blood sugar

- Subjects whose physician will not allow suspension of oral diabetes medications for the duration of the study (~5 weeks)

- Concomitant use of corticosteroids (ingestion, injection or transdermal)

- Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Recommended protein intake
Recommended protein intake diet contained 10% protein, 55% carbohydrate,and 35 % fat.
Elevated protein intake
Recommended protein intake diet contained 20% protein, 45% carbohydrate,and 35 % fat.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Arkansas Dairy Research Institute

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in rate of glucose disappearance Rate of glucose disappearance from plasma to body tissues is a measure of whole body insulin sensitivity Change from baseline and after 4weeks of dietary intervention No
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A